The week in review


It’s been an action-packed week in community pharmacy…

A pub with no beer is bad enough, but this week we also took a look at the town with no medicines… and the residents’ pleas to Health Minister Greg Hunt for a pharmacy of their own.

There was big news on Monday, as we learned that the Guild will no longer be administrating the 6CPA pharmacy programs.

The attacks from the world of doctors continue, with the latest pot shot fired by Medical Republic publisher Jeremy Knibbs, and another by new RACGP chair Charlotte Hespe, who criticised expanded vaccination in NSW pharmacies.

My Health Record is still being examined closely, with the Digital Health Agency saying Australians will have more control over their record than counterparts overseas using other systems; while the PSA‘s Shane Jackson had some thoughts about the importance of being connected.

Pharmacists in the opening round of Advanced Practice have been notified of their credentials. AJP investigated Health Destination Pharmacy and what happened to the program.

And in great news for public health, Australia has been officially declared rubella-free.

Alliance Pharmacy opened a new outlet for daigou. We got a look at TerryWhite Chemmart‘s plans for 2019. And pain stakeholders expressed concern about whether real time monitoring should be implemented before more treatment options are available to those who have problems with prescription drugs… a position echoed by substance abuse stakeholders, who fear the system could drive people to illicit drugs. Real time monitoring was defended in both instances by the Guild’s Anthony Tassone.

We found out who was driving the $1 discount. We examined MedsCheck costs. We looked at what drove the increased cost of formerly-OTC low-dose codeine products. And congratulations to Alice Vanderpol, who has been named Pharmacy Assistant of the Year for 2018!

And the Board reminded pharmacists that you have until the end of the month to renew your registration… the clock is ticking!

Previous Taking a stand
Next MedAdvisor recognised in AFR’s Fast 100 Companies List

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.